ARTICLE | Top Story
Chiron acquires Sagres
July 6, 2004 7:00 AM UTC
CHIR acquired cancer target company Sagres (Davis, Calif.) for an undisclosed sum. Sagres is using its Oncogenome high throughput gene isolation and in vivo biological validation technology to identif...